KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Hologic (HOLX) EBITDA Margin (2016 - 2025)

Hologic's EBITDA Margin history spans 17 years, with the latest figure at 25.13% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 36.0% year-over-year to 25.13%; the TTM value through Dec 2025 reached 18.12%, down 509.0%, while the annual FY2025 figure was 20.08%, 429.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 25.13% at Hologic, up from 22.57% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 51.82% in Q1 2021 and bottomed at 0.7% in Q1 2025.
  • The 5-year median for EBITDA Margin is 24.6% (2022), against an average of 24.57%.
  • The largest annual shift saw EBITDA Margin skyrocketed 3114bps in 2021 before it plummeted -2618bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 43.59% in 2021, then plummeted by -44bps to 24.43% in 2022, then decreased by -20bps to 19.56% in 2023, then increased by 27bps to 24.77% in 2024, then increased by 1bps to 25.13% in 2025.
  • Per Business Quant, the three most recent readings for HOLX's EBITDA Margin are 25.13% (Q4 2025), 22.57% (Q3 2025), and 24.87% (Q2 2025).